Sort by
Items per page

Send to

Choose Destination

Search results

Items: 18


High Resolution AMS Dates from Shubayqa 1, northeast Jordan Reveal Complex Origins of Late Epipalaeolithic Natufian in the Levant.

Richter T, Arranz-Otaegui A, Yeomans L, Boaretto E.

Sci Rep. 2017 Dec 5;7(1):17025. doi: 10.1038/s41598-017-17096-5.


Expansion of the known distribution of Asiatic mouflon (Ovis orientalis) in the Late Pleistocene of the Southern Levant.

Yeomans L, Martin L, Richter T.

R Soc Open Sci. 2017 Aug 23;4(8):170409. doi: 10.1098/rsos.170409. eCollection 2017 Aug.


Emerging Biomarkers of Illness Severity: Urinary Metabolites Associated with Sepsis and Necrotizing Methicillin-Resistant Staphylococcus aureus Pneumonia.

Ambroggio L, Florin TA, Shah SS, Ruddy R, Yeomans L, Trexel J, Stringer KA.

Pharmacotherapy. 2017 Sep;37(9):1033-1042. doi: 10.1002/phar.1973. Epub 2017 Jul 28.


The Construction of Physics as a Quintessentially Masculine Subject: Young People's Perceptions of Gender Issues in Access to Physics.

Francis B, Archer L, Moote J, DeWitt J, MacLeod E, Yeomans L.

Sex Roles. 2017;76(3):156-174. doi: 10.1007/s11199-016-0669-z. Epub 2016 Sep 6.


Macrophage-Mediated Clofazimine Sequestration Is Accompanied by a Shift in Host Energy Metabolism.

Trexel J, Yoon GS, Keswani RK, McHugh C, Yeomans L, Vitvitsky V, Banerjee R, Sud S, Sun Y, Rosania GR, Stringer KA.

J Pharm Sci. 2017 Apr;106(4):1162-1174. doi: 10.1016/j.xphs.2016.12.009. Epub 2016 Dec 20.


1D-¹H-nuclear magnetic resonance metabolomics reveals age-related changes in metabolites associated with experimental venous thrombosis.

Obi AT, Stringer KA, Diaz JA, Finkel MA, Farris DM, Yeomans L, Wakefield T, Myers DD Jr.

J Vasc Surg Venous Lymphat Disord. 2016 Apr;4(2):221-30. doi: 10.1016/j.jvsv.2015.09.010. Epub 2015 Nov 24.


Further Optimization and Evaluation of Bioavailable, Mixed-Efficacy μ-Opioid Receptor (MOR) Agonists/δ-Opioid Receptor (DOR) Antagonists: Balancing MOR and DOR Affinities.

Harland AA, Yeomans L, Griggs NW, Anand JP, Pogozheva ID, Jutkiewicz EM, Traynor JR, Mosberg HI.

J Med Chem. 2015 Nov 25;58(22):8952-69. doi: 10.1021/acs.jmedchem.5b01270. Epub 2015 Nov 13.


Whole Blood Reveals More Metabolic Detail of the Human Metabolome than Serum as Measured by 1H-NMR Spectroscopy: Implications for Sepsis Metabolomics.

Stringer KA, Younger JG, McHugh C, Yeomans L, Finkel MA, Puskarich MA, Jones AE, Trexel J, Karnovsky A.

Shock. 2015 Sep;44(3):200-8. doi: 10.1097/SHK.0000000000000406.


Chemical Analysis of Drug Biocrystals: A Role for Counterion Transport Pathways in Intracellular Drug Disposition.

Keswani RK, Baik J, Yeomans L, Hitzman C, Johnson AM, Pawate AS, Kenis PJ, Rodriguez-Hornedo N, Stringer KA, Rosania GR.

Mol Pharm. 2015 Jul 6;12(7):2528-36. doi: 10.1021/acs.molpharmaceut.5b00032. Epub 2015 Jun 5.


Development of a bioavailable μ opioid receptor (MOPr) agonist, δ opioid receptor (DOPr) antagonist peptide that evokes antinociception without development of acute tolerance.

Mosberg HI, Yeomans L, Anand JP, Porter V, Sobczyk-Kojiro K, Traynor JR, Jutkiewicz EM.

J Med Chem. 2014 Apr 10;57(7):3148-53. doi: 10.1021/jm5002088. Epub 2014 Mar 26.


Translation of structure-activity relationships from cyclic mixed efficacy opioid peptides to linear analogues.

Anand JP, Porter-Barrus VR, Waldschmidt HV, Yeomans L, Pogozheva ID, Traynor JR, Mosberg HI.

Biopolymers. 2014 Jan;102(1):107-14. doi: 10.1002/bip.22437. Erratum in: Biopolymers. 2014 Sep;102(5):426.


Opioid peptidomimetics: leads for the design of bioavailable mixed efficacy μ opioid receptor (MOR) agonist/δ opioid receptor (DOR) antagonist ligands.

Mosberg HI, Yeomans L, Harland AA, Bender AM, Sobczyk-Kojiro K, Anand JP, Clark MJ, Jutkiewicz EM, Traynor JR.

J Med Chem. 2013 Mar 14;56(5):2139-49. doi: 10.1021/jm400050y. Epub 2013 Feb 27.


Phosphorylation of enkephalins: NMR and CD studies in aqueous and membrane-mimicking environments.

Yeomans L, Muthu D, Lowery JJ, Martinez HN, Abrell L, Lin G, Strom K, Knapp BI, Bidlack JM, Bilsky EJ, Polt R.

Chem Biol Drug Des. 2011 Nov;78(5):749-56. doi: 10.1111/j.1747-0285.2011.01203.x. Epub 2011 Sep 26.


Architecture, sedentism, and social complexity at Pre-Pottery Neolithic A WF16, Southern Jordan.

Finlayson B, Mithen SJ, Najjar M, Smith S, Maričević D, Pankhurst N, Yeomans L.

Proc Natl Acad Sci U S A. 2011 May 17;108(20):8183-8. doi: 10.1073/pnas.1017642108. Epub 2011 May 2.


Glycosylation improves the central effects of DAMGO.

Lowery JJ, Yeomans L, Keyari CM, Davis P, Porreca F, Knapp BI, Bidlack JM, Bilsky EJ, Polt R.

Chem Biol Drug Des. 2007 Jan;69(1):41-7.


Glycopeptides related to beta-endorphin adopt helical amphipathic conformations in the presence of lipid bilayers.

Dhanasekaran M, Palian MM, Alves I, Yeomans L, Keyari CM, Davis P, Bilsky EJ, Egleton RD, Yamamura HI, Jacobsen NE, Tollin G, Hruby VJ, Porreca F, Polt R.

J Am Chem Soc. 2005 Apr 20;127(15):5435-48.


Electrostatic forces as a possible mechanism underlying skeletal muscle contraction.

Muñiz J, Marin JL, Yeomans L, Acuña H, Del Castillo LF, Cruz SA, Trujillo X, Huerta M.

Gen Physiol Biophys. 1996 Dec;15(6):441-9.


Effects of growth-hormone release-inhibiting hormone on circulating glucagon, insulin, and growth hormone in normal, diabetic, acromegalic, and hypopituitary patients.

Mortimer CH, Tunbridge WM, Carr D, Yeomans L, Lind T, Coy DH, Bloom SR, Kastin A, Mallinson CN, Besser GM, Schally AV, Hall R.

Lancet. 1974 Apr 20;1(7860):697-701. No abstract available.


Supplemental Content

Loading ...
Support Center